Burning Rock Biotech (BNR) Retained Earnings (2019 - 2026)

Burning Rock Biotech (BNR) has reported Retained Earnings for 8 consecutive years, with -$619.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Retained Earnings fell 6.68% year-over-year to -$619.5 million; the TTM figure through Mar 2026 stood at -$619.5 million (down 6.68% YoY), while the FY2025 annual figure was -$23.2 million, up 95.97% from the prior year.
• Retained Earnings came in at -$619.5 million for Q1 2026 at Burning Rock Biotech, down from -$600.0 million in the prior quarter.
• The five-year high for Retained Earnings was -$22.0 million in Q4 2024, with the low at -$619.5 million in Q1 2026.
• Average Retained Earnings over 5 years is -$494.0 million, with a median of -$535.2 million recorded in 2023.
• Across the five-year window, Retained Earnings jumped 95.89% in 2024 and tumbled 2626.97% in 2025, its largest moves.
• Year by year, Retained Earnings stood at -$449.9 million in 2022, then declined by 18.96% to -$535.2 million in 2023, then surged by 95.89% to -$22.0 million in 2024, then slumped by 2626.97% to -$600.0 million in 2025, then slipped by 3.24% to -$619.5 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$619.5 million, -$600.0 million, and -$595.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.